Prevention of allograft HCV recurrence with peri-transplant human monoclonal antibody MBL-HCV1 combined with a single oral direct-acting antiviral: A proof-of-concept study.
J Viral Hepat
; 24(3): 197-206, 2017 03.
Article
in En
| MEDLINE
| ID: mdl-28127942
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Liver Transplantation
/
Hepatitis C
/
Hepatitis C Antibodies
/
Secondary Prevention
/
Antibodies, Monoclonal
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Viral Hepat
Journal subject:
GASTROENTEROLOGIA
Year:
2017
Type:
Article
Affiliation country:
United States